Zobrazeno 1 - 10
of 211
pro vyhledávání: '"Ralf Stahlmann"'
Publikováno v:
Archives of Toxicology. 97:1677-1689
Established in vitro assays for regulatory testing of skin sensitisation partly suffer from only moderate sensitivity, specificity, and predictivity when testing specific groups of chemicals. This may be due to limited biomarker response in vitro in
Autor:
Tom Schaberg, Folke Brinkmann, Cornelia Feiterna-Sperling, Hilte Geerdes-Fenge, Pia Hartmann, Brit Häcker, Barbara Hauer, Walter Haas, Jan Heyckendorf, Christoph Lange, Florian P. Maurer, Albert Nienhaus, Ralf Otto-Knapp, Martin Priwitzer, Elvira Richter, Helmut J.F. Salzer, Otto Schoch, Nicolas Schönfeld, Ralf Stahlmann, Torsten Bauer
Publikováno v:
Pneumologie. 76:727-819
ZusammenfassungDie Tuberkulose ist in Deutschland eine seltene, überwiegend gut behandelbare Erkrankung. Weltweit ist sie eine der häufigsten Infektionserkrankungen mit ca. 10 Millionen Neuerkrankungen/Jahr. Auch bei einer niedrigen Inzidenz in Deu
Autor:
Tom, Schaberg, Folke, Brinkmann, Cornelia, Feiterna-Sperling, Hilte, Geerdes-Fenge, Pia, Hartmann, Brit, Häcker, Barbara, Hauer, Walter, Haas, Jan, Heyckendorf, Christoph, Lange, Florian P, Maurer, Albert, Nienhaus, Ralf, Otto-Knapp, Martin, Priwitzer, Elvira, Richter, Helmut J F, Salzer, Otto, Schoch, Nicolas, Schönfeld, Ralf, Stahlmann, Torsten, Bauer
Publikováno v:
Pneumologie (Stuttgart, Germany). 76(11)
In Germany tuberculosis is a rare disease and usually well treatable. Worldwide it is one of the most common infectious diseases with approximately 10 million new cases every year. Even with low incidences in Germany, tuberculosis is an important dif
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 86
Skin sensitisation involves activation of dendritic cells which activate T cells and induce their clonal expansion. While the first step is covered by OECD-validated new approach methodologies, the latter is not until now. This may be due to a weak d
Publikováno v:
Zahnmedizin up2date. 13:299-317
Autor:
Thomas R. Weihrauch, Hans-Christoph Diener, Justus Duyster, Matthias Girndt, Viola Hach-Wunderle, Dieter Häussinger, Uta C. Hoppe, Carl M. Kirchmaier, Hartmut Lode, Elisabeth Märker-Hermann, Christoph M. Niederau, Thomas Poralla, Kurt Rasche, Martin Ruß, Werner A. Scherbaum, Helmut Schinzel, Matthias Schott, Ralf Stahlmann, Petra A. Thürmann, Raymond Voltz, Martin R. Weihrauch, Annette Welz-Barth, René R. Wenzel, Eberhard Windler, Thomas Zander, B.-Chr. Zyriax, Jürgen Heinz, Brigitte M. Lobnig, Benedikt C. Ostendorf, Daniele Pillitteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fc69ea089ce702ac41727c6217b68c4
https://doi.org/10.1016/b978-3-437-41655-2.01002-2
https://doi.org/10.1016/b978-3-437-41655-2.01002-2
Autor:
Ralf, Stahlmann, Hartmut, Lode
Publikováno v:
GMS Infectious Diseases
This is the fourth chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2Dies ist das vierte Kapitel der von der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) herausgegebe
Autor:
Ralf Stahlmann, Hartmut Lode
Publikováno v:
Deutsches Ärzteblatt International
BACKGROUND: With the worldwide spread of SARS-CoV-2 infection, it is becoming increasingly urgent to develop a vaccine to prevent COVID-19, as well as effective drugs to treat it. METHODS: This article is based on a selective literature search in Pub